Differential expression of CD26 on virus-specific CD8+ T cells during active, latent and resolved infection

被引:34
作者
Ibegbu, Chris C. [1 ,5 ]
Xu, Yong-Xian [1 ,5 ]
Fillos, Dimitri [1 ,5 ]
Radziewicz, Henry [2 ,3 ]
Grakoui, Arash [2 ,3 ]
Kourtis, Athena P. [4 ]
机构
[1] Emory Univ, Sch Med, Ctr AIDS Res, Immunol Core Lab, Atlanta, GA 30329 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30329 USA
[3] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30329 USA
[4] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
[5] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA
关键词
CD26; CD8(+) T cells; T-cell markers; virus-specific; VIRAL-INFECTIONS; MEMORY CELLS; GENERATION; LYMPHOCYTES; MATURATION; SUBSETS;
D O I
10.1111/j.1365-2567.2008.02899.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The hallmark of effective establishment of immune memory is the long-term memory cell that persists in the absence of antigen. To explore its characteristics, we investigated the differences between a resolved successful immune response, such as after influenza (flu) vaccination, and the state of chronic infection with persistent antigen, such as with cytomegalovirus (CMV), Epstein-Barr virus (EBV) or human immunodeficiency virus (HIV), which leads to defective T-cell memory. Immunophenotypic analyses using multi-parameter flow cytometry and tetramer technology identified a unique pattern of CD26(high) expression among influenza-specific CD8(+) T cells, but not among CD8(+) T cells specific for CMV, EBV (three different epitopes) or HIV. The median percentage of CD8(+) T cells expressing CD26 was 95.5% for influenza, but for cells specific for CMV, EBV and HIV it was 10.5%, 12%-19%, and 13.2%, respectively. These findings suggest that expression of CD26(high) may be a characteristic of a memory cell. CD26(high) expression correlates with expression of CD127, a marker of memory cells. Furthermore, CD26(high) cells can produce interleukin-2. These findings offer insight into the dynamics of T-cell differentiation, and they may offer a specific marker of a successfully developed memory CD8(+) T cell, that of CD26(high). This marker has the potential to be useful in studies of immune responses to infectious agents, and to new vaccine candidates.
引用
收藏
页码:346 / 353
页数:8
相关论文
共 27 条
[1]   Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection [J].
Alter, G ;
Hatzakis, G ;
Tsoukas, CM ;
Pelley, K ;
Rouleau, D ;
LeBlanc, R ;
Baril, JG ;
Dion, H ;
Lefebvre, E ;
Thomas, R ;
Côté, P ;
Lapointe, N ;
Routy, JP ;
Sékaly, RP ;
Conway, B ;
Bernard, NF .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :477-488
[2]   Lessons from the study of T-cell differentiation in persistent human virus infection [J].
Appay, V ;
Rowland-Jones, SL .
SEMINARS IN IMMUNOLOGY, 2004, 16 (03) :205-212
[3]   Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[4]  
BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073
[5]  
Brostrom C, 1998, CLIN DIAGN LAB IMMUN, V5, P662
[6]   Signaling control of memory T cell generation and function [J].
Chandok, MR ;
Farber, DL .
SEMINARS IN IMMUNOLOGY, 2004, 16 (05) :285-293
[7]   CD26, let it cut or cut it down [J].
De Meester, I ;
Korom, S ;
Van Damme, J ;
Scharpé, S .
IMMUNOLOGY TODAY, 1999, 20 (08) :367-375
[8]   Memory T cells and vaccines [J].
Esser, MT ;
Marchese, RD ;
Kierstead, LS ;
Tussey, LG ;
Wang, FB ;
Chirmule, N ;
Washabaugh, MW .
VACCINE, 2003, 21 (5-6) :419-430
[9]   Influence of CD26 and integrins on the antigen sensitivity of human memory T cells [J].
Falcioni, F ;
Shah, H ;
Vidovic, D ;
Morimoto, C ;
Belunis, C ;
Bolin, D ;
Nagy, ZA .
HUMAN IMMUNOLOGY, 1996, 50 (02) :79-90
[10]  
HAFLER DA, 1989, J IMMUNOL, V142, P2590